Abstract
The present invention relates to solid-state forms of small-molecule kinase inhibitors. In particular, it relates to an amorphous form of Zongertinib (hereinafter “the compound” or “Zongertinib”), processes for its preparation, compositions comprising the amorphous form, and their use in therapy.
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.
Recommended Citation
Venukathala, Prashanth and Venukathala, Prashanth, "AMORPHOUS FORM OF ZONGERTINIB, PROCESSES FOR PREPARATION, AND PHARMACEUTICAL COMPOSITIONS THEREOF", Technical Disclosure Commons, (September 05, 2025)
https://www.tdcommons.org/dpubs_series/8564
COinS